Detrunorm XL 30 mg Modified-Release Capsules
*Company:
Consilient Health LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 30 November 2023
File name
pl-detrunormXL30-aug23-v002uk-ie-layout-1.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 11 October 2023
File name
ie-pl.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 11 October 2023
File name
ie-spc.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 22 July 2021
File name
ie-spc-clean-coa-may2021.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 22 July 2021
File name
P1287 - appr. 20.07.2021.pdf
Reasons for updating
- New PIL for new product
Consilient Health Ltd
Address:
Block 2A Richview Office Park, Clonskeagh, Dublin 14, IrelandMedical Information E-mail:
drugsafety@consilienthealth.comTelephone:
353 1 2057760Medical Information Facsimile:
+44 (0) 203 751 1889Medical Information Direct Line:
+44 (0) 203 751 1888